Karma Bio Health is dedicated to creating
advanced performance pharmaceutical formulations.
Using our proprietary excipients, Zenergy™ and Rhesolv™, we formulate drugs for higher bioavailability, faster onset, and easier administration. Drugs previously available only via injections can now be given in nasal, inhalation and oral formats, resulting in better performance with higher patient compliance and satisfaction.
In addition, Karma Bio utilizes cutting-edge digital dispensing technology that can make our formulations easier and safer for use, allowing log-and-lock capabilities to reduce issues around diversion, overdosing and abuse, while simultaneously allowing greater insight into patient use characteristics and enabling seamless EHR integration to facilitate better care where appropriate.
Glen Cunningham,
MBA, BSN,BSc,RN
Chief Executive Officer
Charles Bentz,
MD, FACP
Chief Medical Officer
Sammi Molvi,
RPh, B. Pharm, B.S. Business
Chief Scientific Officer
Kirk Gerner,
Chair
Sinhow Chin,
CFO